In Brief This Week: 454 Life Sciences; Waters; Agencourt; Illumina; Pathwork Diagnostics; and More | GenomeWeb

NEW YORK (GenomeWeb News) – Roche's 454 Life Sciences said this week that its Genome Sequencer FLX has been installed at the University of Barcelona in Spain. The university's Genomics Unit of the Scientific and Technical Services will use the platform to study aquaculture and DNA alterations related to human diseases.


Waters said that the National Cancer Institute's Center for Cancer Research has purchased an Acquity UPLC/Synapt HDMS system and an Acquity UPLC/Xevo TQ MS system for use in its metabolomics research programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.